EUVIMEDEUVIMED entdecken
Crossref

Discovery of anti-inflammatory β-acids featuring an unusual 5/7/5 tricyclic skeleton via targeting the TLR4/MyD88 signaling pathway

Kang Ding, Fu-Lin Zhou, Yan-Jing Shi, Zi-Hao Sha, Li-Jie Wang, Jia Zhang, Mao-Li Bai, Zhou-Zi-Qi Li, Jie-Kun Xu, Jun He, Wei-Ku Zhang

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.110415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Kang Ding und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medical Sciences & Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, P. R. China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Myeloid Differentiation Factor 88, Anti-Inflammatory Agents, Non-Steroidal, Drug Discovery. Die Arbeit nennt 15 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, China-Japan Friendship Hospital, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Five pairs of previously undescribed β-acid enantiomers, (±)-humulunes A-E (1-5), were isolated from Humulus lupulus L. These compounds feature an unusual 5/7/5 tricyclic ring skeleton bearing multiple stereocenters. Their structures were elucidated through comprehensive spectroscopic analysis, including calculated NMR and electronic circular dichroism (ECD), as well as single-crystal X-ray diffraction. Among them, compounds (+)-3, (-)-3, and (+)-4 exhibited significant anti-inflammatory activity in LPS-induced RAW 264.7 cells. Furthermore, compound (-)-3 was found to inhibit cell apoptosis and reactive oxygen species (ROS) production, modulate macrophage polarization, and suppress the TLR4/MyD88 signaling pathway. Molecular docking, molecular dynamics simulation, and cellular thermal shift assay (CETSA) confirmed the direct and stable binding of (-)-3 to TLR4 protein, which may exert anti-inflammatory effects by blocking the activation of the TLR4/MyD88 signaling pathway, providing a reference for the development of anti-inflammatory therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4Myeloid Differentiation Factor 88Anti-Inflammatory Agents, Non-SteroidalDrug DiscoveryAnti-Inflammatory AgentsAnimalsMiceSignal TransductionRAW 264.7 CellsStructure-Activity RelationshipMolecular StructureLipopolysaccharidesMolecular Docking SimulationDose-Response Relationship, DrugApoptosisReactive Oxygen Species

Stichwörter der Autor:innen

(±)-Humulunes A-EAnti-inflammatory activityTLR4Tricyclic β-acids

Substanzen

Toll-Like Receptor 4Myeloid Differentiation Factor 88LipopolysaccharidesAnti-Inflammatory Agents, Non-SteroidalTlr4 protein, mouseMyd88 protein, mouseReactive Oxygen SpeciesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Institute of Clinical Medical Sciences & Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, P. R. China.
  • China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100029, P. R. China.
  • School of Life Sciences & School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, P. R. China.
  • School of Life Sciences & School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, P. R. China. Electronic address: xjkbucm@163.com.
  • Institute of Clinical Medical Sciences & Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, P. R. China. Electronic address: 15010297582@126.com.
  • Institute of Clinical Medical Sciences & Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, P. R. China. Electronic address: cpuzwk@163.com.

Förderung

  • Chinese Academy of Medical Sciences
  • China-Japan Friendship Hospital
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Ding, K., Zhou, F. L., Shi, Y. J., Sha, Z. H., Wang, L. J., Zhang, J., Bai, M. L., Li, Z. Z., Xu, J. K., He, J., & Zhang, W. K. (2026). Discovery of anti-inflammatory β-acids featuring an unusual 5/7/5 tricyclic skeleton via targeting the TLR4/MyD88 signaling pathway. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110415

Vancouver

Ding K, Zhou FL, Shi YJ, Sha ZH, Wang LJ, Zhang J, et al. Discovery of anti-inflammatory β-acids featuring an unusual 5/7/5 tricyclic skeleton via targeting the TLR4/MyD88 signaling pathway. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110415

BibTeX
@article{Ding2026,
  author = {Ding, Kang and Zhou, Fu-Lin and Shi, Yan-Jing and Sha, Zi-Hao and Wang, Li-Jie and Zhang, Jia and Bai, Mao-Li and Li, Zhou-Zi-Qi and Xu, Jie-Kun and He, Jun and Zhang, Wei-Ku},
  title = {Discovery of anti-inflammatory β-acids featuring an unusual 5/7/5 tricyclic skeleton via targeting the TLR4/MyD88 signaling pathway},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.110415}
}
Kostenlos starten →